Galena Biopharma Inc


Biotech Beat: Roth Capital Analysts Weigh In on Galena Biopharma Inc (GALE) and BioDelivery Sciences International, Inc. (BDSI)

Roth Capital analysts weigh in on the small-cap biotech company Galena Biopharma Inc (NASDAQ:GALE) and drug delivery company BioDelivery Sciences International, Inc. (NASDAQ:BDSI) after both companies …

Galena Biopharma Inc (GALE) Reports Third Quarter 2015 Financial Results

Galena Biopharma Inc (NASDAQ:GALE), a biopharmaceutical company committed to the development and commercialization of targeted oncology therapeutics that address major unmet medical needs, today …

Stock Update (NASDAQ:GALE): Galena Biopharma Inc Presents GALE-302 Preliminary Immunologic Data Optimizing GALE-301 at the SITC 30th Anniversary Annual Meeting

Galena Biopharma Inc (NASDAQ:GALE), a biopharmaceutical company developing and commercializing innovative, targeted oncology therapeutics that address major medical needs across the full spectrum of …

Wall Street’s Week Ahead: MannKind Corporation (MNKD), Intercept Pharmaceuticals Inc (ICPT), Galena Biopharma Inc (GALE), Juno Therapeutics Inc (JUNO)

Several pharmaceutical giants will be releasing earnings reports this week. Here’s what to watch for in reports from MannKind Corporation (NASDAQ:MNKD), Intercept Pharmaceuticals …

Stock Update (NASDAQ:GALE): Galena Biopharma Inc Appoints Bijan Nejadnik, M.D., as Executive Vice President and Chief Medical Officer

Galena Biopharma Inc (NASDAQ:GALE), a biopharmaceutical company developing and commercializing innovative, targeted oncology therapeutics that address major medical needs across the full spectrum of …

Stock Update (NASDAQ:GALE): Galena Biopharma Inc to Present Clinical Data at Two Upcoming Medical Conferences

Galena Biopharma, Inc. (NASDAQ:GALE), a biopharmaceutical company developing and commercializing innovative, targeted oncology therapeutics that address major medical needs across the full spectrum of …

Company Update (NASDAQ:GALE): Galena Biopharma Inc Collaborates With the National Cancer Institute on a Phase 2 Clinical Trial With NeuVax in Ductal Carcinoma in Situ Patients

Galena Biopharma Inc (NASDAQ:GALE), a biopharmaceutical company developing and commercializing innovative, targeted oncology therapeutics that address major medical needs across the full spectrum of …

Maxim Weighs In on Two Biotech Stocks: Galena Biopharma Inc (GALE), AEterna Zentaris Inc. (USA) (AEZS)

Maxim analysts are weighing in on the small-cap biopharmaceutical company Galena Biopharma Inc (NASDAQ:GALE), and Canadian biotech company AEterna Zentaris Inc. (USA) (NASDAQ:AEZS), after the companies presented clinical data …

Maxim Reiterates Buy on Galena Biopharma Inc Following GALE-301 Phase 2a Clinical Data Release

In a research report published today, Maxim analyst Jason McCarthy reiterated a Buy rating on shares of Galena Biopharma Inc (NASDAQ:GALE) with a $7 price …

Stock Update (NASDAQ:GALE): Galena Biopharma Inc Presents Positive GALE-301 Phase 2a Clinical Trial Data at the European Cancer Congress 2015

Galena Biopharma Inc (NASDAQ:GALE), a biopharmaceutical company developing and commercializing innovative, targeted oncology therapeutics that address major medical needs across the full spectrum of …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts